References
- HaismaHJBelluARPharmacological interventions for improving adenovirus usage in gene therapyMol Pharm201181505520979428
- MatthewsQLCapsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approachMol Pharm20118131121047139
- RenteriaSSClemensCCCroyleMADevelopment of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devicesVaccine20102892137214820044048
- Gene therapy clinical trials worldwide [database on the Internet]J Gene Med Available from: http://www.wiley.com//legacy/wileychi/genmed/clinical/Accessed January 25, 2011
- HorowitzJAdenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applicationsCurr Opin Mol Ther19991450050911713766
- MaGShimadaHHiroshimaKTadaYSuzukiNTagawaMGene medicine for cancer treatment: commercially available medicine and accumulated clinical data in ChinaDrug Des Devel Ther20092115122
- SinghRKostarelosKDesigner adenoviruses for nanomedicine and nanodiagnosticsTrends Biotechnol200927422022919251331
- WuTLErtlHCImmune barriers to successful gene therapyTrends Mol Med2009151323919101205
- ZaissAKMachadoHBHerschmanHRThe influence of innate and pre-existing immunity on adenovirus therapyJ Cell Biochem2009108477879019711370
- ZhongZHanJWanYZhangZSunXAnionic liposomes enhance and prolong adenovirus-mediated gene expression in airway epithelia in vitro and in vivoMol Pharm20118367368221510701
- SunCZhangYFengLEpidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern ChinaVaccine201129223837384121447314
- MastTCKiersteadLGuptaSBInternational epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type- 36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trialsVaccine201028495095719925902
- PilankattaRChawlaTKhannaNSwaminathanSThe prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccinesJ Med Virol201082340741420087930
- SinghRTianBKostarelosKArtificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivoFASEB J20082293389340218556649
- EtoYYoshiokaYIshidaTOptimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancerBiol Pharm Bull20103391540154420823571
- MokHPalmerDJNgPBarryMAEvaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responsesMol Ther2005111667915585407
- EtoYGaoJQSekiguchiFNeutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA)Biol Pharm Bull200427693693815187452
- CroyleMAChirmuleNZhangYWilsonJM“Stealth” adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lungJ Virol200175104792480111312351
- KimPHSohnJHChoiJWActive targeting and safety profile of PEG-modified adenovirus conjugated with herceptinBiomaterials20113292314232621227505
- LeeGKMaheshriNKasparBSchafferDVPEG conjugation moderately protects adeno-associated viral vectors against antibody neutralizationBiotechnol Bioeng2005921243415937953
- O’RiordanCRLachapelleADelgadoCPEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivoHum Gene Ther19991081349135810365665
- EtoYYoshiokaYMukaiYOkadaNNakagawaSDevelopment of PEGylated adenovirus vector with targeting ligandInt J Pharm20083541–23817904316
- JungYParkHJKimPHRetargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cellsJ Control Release2007123216417117854941
- Suzuki-KouyamaEKatayamaKSakuraiFHexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interactionBiomaterials20113261724173021106235
- WortmannAVöhringerSEnglerTFully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodiesMol Ther200816115416217848961
- WangIJJhuangMCChenYHYehLKLiuCYYoungTHChitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cellsPLoS One201058e1208520711466
- FasbenderAZabnerJChillónMComplexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivoJ Biol Chem199727210647964899045673
- SteelJCCavanaghHMBurtonMADingwallDJKalleWHModification of liposomal concentration in liposome/adenoviral complexes allows significant protection of adenoviral vectors from neutralising antibody, in vitroJ Virol Methods20051261–2313615847916
- DoddsEPiperTAMurphySJDicksonGCationic lipids and polymers are able to enhance adenoviral infection of cultured mouse myotubesJ Neurochem19997252105211210217291
- MoselhyJSarkarSChiaMCEvaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinomaInt J Nanomedicine20072346147818019844
- LvHZhangSWangBCuiSYanJToxicity of cationic lipids and cationic polymers in gene deliveryJ Control Release2006114110010916831482
- AhnCHChaeSYBaeYHKimSWSynthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrierJ Control Release200497356757415212887
- LiangBHeMLXiaoZPSynthesis and characterization of folate- PEG-grafted-hyperbranched-PEI for tumor-targeted gene deliveryBiochem Biophys Res Commun2008367487488018201560
- LaiWFLinMCNucleic acid delivery with chitosan and its derivativesJ Control Release2009134315816819100795
- EtoYGaoJQSekiguchiFPEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion abilityJ Gene Med20057560461215543536
- YamashitaMInoAKawabataKSakuraiFMizuguchiHExpression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cellsInt J Cancer200712181690169617546646
- KimJSLeeSHChoYSChoiJJKimYHLeeJHEnhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR)Gynecol Oncol200285226026511972385
- KoyamaYItoTMatsumotoHNovel poly(ethylene glycol) derivatives with carboxylic acid pendant groups: synthesis and their protection and enhancing effect on non-viral gene transfection systemsJ Biomater Sci Polym Ed200314651553112901435
- HanSMahatoRISungYKKimSWDevelopment of biomaterials for gene therapyMol Ther20002430231711020345
- FisherKDSeymourLWHPMA copolymers for masking and retargeting of therapeutic virusesAdv Drug Deliv Rev201062224024520005911
- SubrVKostkaLSelby-MilicTCoating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood componentsJ Control Release2009135215215819166885
- HofherrSEMokHGushikenFCLopezJABarryMAPolyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopeniaHum Gene Ther200718983784817767399
- DoroninKShashkovaEVMaySMHofherrSEBarryMAChemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusHum Gene Ther200920997598819469693
- HofherrSEShashkovaEVWeaverEAKhareRBarryMAModification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expressionMol Ther20081671276128218461056
- KimP-HKimTIYockmanJWKimSWYunCOThe effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapyBiomaterials20103171865187419962189
- HanJZhaoDZhongZZhangZGongTSunXCombination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transductionNanotechnology20102110105106
- KasmanLMBaruaSLuPRegeKVoelkel-JohnsonCPolymer-enhanced adenoviral transduction of CAR-negative bladder cancer cellsMol Pharm2009651612161919655763
- KelkarSAPfisterKKCrystalRGLeopoldPLCytoplasmic dynein mediates adenovirus binding to microtubulesJ Virol20047818101221013215331745
- MorralNO’NealWKRiceKLethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboonsHum Gene Ther200213114315411779418
- Medina-KauweLKEndocytosis of adenovirus and adenovirus capsid proteinsAdv Drug Deliv Rev200355111485149614597142
- MeierOGreberUFAdenovirus endocytosisJ Gene Med20046Suppl 1S15216314978758
- DavisHEMorganJRYarmushMLPolybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranesBiophys Chem2002972–315917212050007
- CarlisleRCDiYCernyAMHuman erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Blood200911391909191819131551
- DavisHERosinskiMMorganJRYarmushMLCharged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregationBiophys J20048621234124214747357
- YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
- FisherKDGreenNKHaleASubrVUlbrichKSeymourLWPassive tumour targeting of polymer-coated adenovirus for cancer gene therapyJ Drug Target2007157–854655117671901
- GodbeyWTWuKKMikosAGPoly(ethylenimine) and its role in gene deliveryJ Control Release1999602–314916010425321
- WeissSISieverlingNNiclasenMUronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriersBiomaterials200627102302231216337267
- ParkJWMokHParkTGPhysical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transductionJ Control Release2010142223824419913577
- GreenNKHerbertCWHaleSJExtended plasma circulation time and decreased toxicity of polymer-coated adenovirusGene Ther200411161256126315215884